RxDoctor Payments Data

Teasia Williams

Psychiatric/Mental Health · Kingston, NYNPI 1245840073

Payments from drug & device makers

$2,404in general payments, 2019–2025

Across 140 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$825
  • Teva Pharmaceuticals USA, Inc.$412
  • Otsuka America Pharmaceutical, Inc.$237
  • Vanda Pharmaceuticals Inc.$173
  • Sunovion Pharmaceuticals Inc.$166
  • Eisai Inc.$153
  • plus $437 from 8 others

What the payments were for

  • Food & beverage$2,404100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,404 in reported general payments places this provider in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$25,940
Medicare patients
42
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine13$108,805
Invega SustennaPaliperidone Palmitate19$44,329
Bupropion XlBupropion Hcl65$9,056
VyvanseLisdexamfetamine Dimesylate18$8,254
XanaxAlprazolam12$7,915
Duloxetine Hcl33$3,916
Quetiapine Fumarate140$2,444
Sertraline Hcl85$2,209
Gabapentin65$1,894
Aripiprazole59$1,463
Olanzapine77$1,342
Ramelteon12$1,294
Clozapine18$1,262
Haloperidol Decanoate13$1,246
Fluvoxamine Maleate21$1,089

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$412$108,80513 claims
Johnson & JohnsonInvega Sustenna$33$44,32919 claims
Almatica Pharma LLCSertraline Hcl$25$2,20985 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Kingston

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →